Fusion Fuel Reports First Half 2026 Results and Expects Full-Year Revenue Growth of 11–25%

Fusion Fuel reported first-half 2026 revenue of approximately €6.5 million, down 5.7% from €6.9 million a year earlier, while its non-IFRS adjusted operating loss improved approximately 25% to €1.8 million. The company expects 2026 revenue of approximately €16 million to €18 million versus €14.4 million in 2025, with a lower adjusted operating loss and increased net assets. It completed the acquisition of Royal Uranium on July 21, adding interests in 16 uranium-focused and three natural gas project areas; operating highlights also included Spain green-hydrogen project execution and about $3.5 million in new LPG engineering subcontracts.

Analysis

The key issue is execution, not the headline growth outlook: after €6.5m of first-half revenue, the €16–18m full-year range implies €9.5–11.5m in the second half—roughly 46–77% above first-half revenue. That back-end loading makes project timing and revenue recognition the near-term share-price drivers. The LPG subcontract wins and Spanish hydrogen project are potential conversion sources, but the release does not establish how much is contracted, recognized in 2026, or incremental to the outlook.

The adjusted-loss improvement is encouraging but not yet evidence of cash-flow inflection. The gap between reported and adjusted operating loss, including acquired-intangible amortization, makes cash burn, working-capital needs, and any financing or dilution risk important items to verify. Royal Uranium adds longer-dated commodity optionality and portfolio complexity; absent disclosed near-term royalty receipts, it should not be capitalized as current earnings support. This is not a clean read-through for hydrogen peers: HTOO’s mixed LPG, project-engineering, and uranium exposure weakens simple sector comparisons.

Over the next 1–3 months, monitor contract conversion, cash and liquidity disclosures, and any guidance change. Over 6–18 months, the thesis depends on repeatable project delivery and demonstrable cash-generating value from acquired interests. Contrarian risk: investors may over-credit headline guidance and acquisition breadth while underweighting the steep H2 delivery hurdle. Failure to reach the outlook, worsening cash conversion, or financing that materially dilutes shareholders would falsify the constructive case.

Key Decisions for Investors

• No immediate directional trade: the outlook is potentially supportive, but the implied second-half revenue acceleration and missing cash-flow detail leave execution and financing risk unresolved.
• Treat HTOO as an event-driven watchlist name; reassess after the next results or update that provides revenue conversion, cash balance, working-capital movement, and share-count/funding detail.
• Constructive trigger: evidence that contracted LPG and hydrogen work is converting into recognized revenue while cash consumption stabilizes. Reconsider or avoid the long thesis if guidance is cut, project milestones slip, or additional funding is required on dilutive terms.
• Do not value the Royal Uranium interests as near-term earnings without disclosed royalty receipts or project-level economics; track updates on attributable cash flows and the timing of any material contribution.